The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Pregnancy outcomes after maternal exposure to rituximab
Open accessAbstract
Rituximab is a chimeric anti-CD20 monoclonal B cell–depleting antibody indicated for certain hematologic malignancies and active rheumatoid arthritis with inadequate response to tumor necrosis factor antagonists. Despite counseling to avoid pregnancy, women may inadvertently become pregnant during or after rituximab treatment. Using the rituximab global drug safety database, we identified 231 pregnancies associated with maternal rituximab exposure. Maternal indications included lymphoma, autoimmune cytopenias, and other autoimmune diseases. Most cases were confounded by concomitant use of potentially teratogenic medications and severe underlying disease. Of 153 pregnancies with known outcomes, 90 resulted in live births. Twenty-two infants were born prematurely; with one neonatal death at 6 weeks. Eleven neonates had hematologic abnormalities; none had corresponding infections. Four neonatal infections were reported (fever, bronchiolitis, cytomegalovirus hepatitis, and chorioamnionitis). Two congenital malformations were identified: clubfoot in one twin, and cardiac malformation in a singleton birth. One maternal death from pre-existing autoimmune thrombocytopenia occurred. Although few congenital malformations or neonatal infections were seen among exposed neonates, women should continue to be counseled to avoid pregnancy for ≤ 12 months after rituximab exposure; however, inadvertent pregnancy does occasionally occur. Practitioners are encouraged to report complete information to regulatory authorities for all pregnancies with suspected or known exposure to rituximab.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001
Finer, L. B., & Henshaw, S. K. (2006) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3809006 · Cited by 1,557
Use of chemotherapy during human pregnancy
Cardonick, E., & Iacobucci, A. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01466-4 · Cited by 838
The Enigma of Spontaneous Preterm Birth
Muglia, L. J., & Katz, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0904308 · Cited by 682
Anti-inflammatory and immunosuppressive drugs and reproduction
Østensen, M., Khamashta, M. A., Lockshin, M. D., Parke, A. L., Brucato, A. L., Carp, H., Doria, A., Rai, R., Meroni, P. L., Cetin, I., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1957 · Cited by 550
de Man, Y. A., Hazes, J. M. W., van der Heide, H., Willemsen, S. P., de Groot, C. J. M., Steegers, E. A. P., & Dolhain, R. J. E. M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24914 · Cited by 361
A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura
Webert, K. E., Mittal, R., Sigouin, C., Heddle, N. M., & Kelton, J. G. (2003) · Blood · doi:10.1182/blood-2002-10-3317 · Cited by 300
Clowse, M. E. B. (2007) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2007.01.002 · Cited by 285
Lu, T. Y. ‐., Ng, K. P., Cambridge, G., Leandro, M. J., Edwards, J. C. W., Ehrenstein, M., & Isenberg, D. A. (2009) · Arthritis Care & Research · doi:10.1002/art.24341 · Cited by 275
Dynamics of immunoglobulins at the feto-maternal interface
Saji, F. (1999) · Reviews of Reproduction · doi:10.1530/revreprod/4.2.81 · Cited by 265
Rituximab Administration in Third Trimester of Pregnancy Suppresses Neonatal B-Cell Development
Klink, D. T., van Elburg, R. M., Schreurs, M. W. J., & van Well, G. T. J. (2008) · Clinical and Developmental Immunology · doi:10.1155/2008/271363 · Cited by 239
Cited by
Provan, D., Stasi, R., Newland, A. C., Blanchette, V. S., Bolton-Maggs, P., Bussel, J. B., Chong, B. H., Cines, D. B., Gernsheimer, T. B., Godeau, B., et al. (2010) · Blood · doi:10.1182/blood-2009-06-225565 · Cited by 2,271
Scully, M., Hunt, B. J., Benjamin, S., Liesner, R., Rose, P., Peyvandi, F., Cheung, B., Machin, S. J., & on behalf of British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09167.x · Cited by 863
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Buch, M. H., Smolen, J. S., Betteridge, N., Breedveld, F. C., Burmester, G., Dörner, T., Ferraccioli, G., Gottenberg, J.-E., Isaacs, J., Kvien, T. K., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.144998 · Cited by 453
Sammaritano, L. R., Bermas, B. L., Chakravarty, E. E., Chambers, C., Clowse, M. E. B., Lockshin, M. D., Marder, W., Guyatt, G., Branch, D. W., Buyon, J., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24130 · Cited by 323
Self-citationHow I treat thrombocytopenia in pregnancy
Gernsheimer, T., James, A. H., & Stasi, R. (2013) · Blood · doi:10.1182/blood-2012-08-448944 · Cited by 275
Metadata
- Authors
- Chakravarty, E. F., Murray, E. R., Kelman, A., & Farmer, P.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-02-03
- Volume
- 117
- Issue
- 5
- Pages
- 1499-1506
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2080663859
- Cited by
- 586
- References
- 18
- FWCI
- 23.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pregnancy outcomes after maternal exposure to rituximab. https://app.cochat.ai/papers/10.1182/blood-2010-07-295444
- The paper
- Chakravarty, E. F., Murray, E. R., Kelman, A., & Farmer, P. (2011). Pregnancy outcomes after maternal exposure to rituximab. Blood. https://doi.org/10.1182/blood-2010-07-295444
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.